Y M Rustum Selected Research

Y M Rustum Research Topics

9	Neoplasms (Cancer) 04/2006 - 01/2000
4	Colorectal Neoplasms (Colorectal Cancer) 09/2003 - 04/2000
3	Carcinoma (Carcinomatosis) 12/2000 - 03/2000
2	Squamous Cell Carcinoma of Head and Neck 04/2006 - 02/2000
1	Hypoxia (Hypoxemia) 04/2006
1	Disease Progression 03/2001

6	Irinotecan (Camptosar)FDA LinkGeneric 04/2006 - 02/2000
5	Fluorouracil (Carac)FDA LinkGeneric 11/2005 - 01/2000
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 03/2001 - 03/2000
2	raltitrexed (D 1694)IBA 12/2000 - 02/2000
2	eniluracilIBA 11/2000 - 04/2000
2	Leucovorin (Folinic Acid)FDA Link 07/2000 - 01/2000
1	selenomethylselenocysteine (methylselenocysteine)IBA 04/2006
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 04/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2006
1	DNA (Deoxyribonucleic Acid)IBA 11/2005
1	Gemcitabine FDA Link 11/2005
1	Cyclin AIBA 11/2005
1	Capecitabine (Xeloda)FDA Link 09/2003
1	CamptothecinIBA 03/2001
1	5-fluorodihydrouracilIBA 04/2000
1	Thymidine KinaseIBA 04/2000
1	Thymidylate SynthaseIBA 04/2000
1	alpha-fluoro-beta-alanine (FBAL)IBA 04/2000
1	Antineoplastic Agents (Antineoplastics)IBA 03/2000
1	Checkpoint Kinase 1IBA 03/2000
1	cositecanIBA 03/2000
1	Topoisomerase I InhibitorsIBA 03/2000
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 02/2000
1	UracilIBA 01/2000
1	TegafurIBA 01/2000